151 related articles for article (PubMed ID: 22513431)
1. Genetic variation in the transforming growth factor-β-signaling pathway, lifestyle factors, and risk of colon or rectal cancer.
Slattery ML; Lundgreen A; Wolff RK; Herrick JS; Caan BJ
Dis Colon Rectum; 2012 May; 55(5):532-40. PubMed ID: 22513431
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in bone morphogenetic protein and colon and rectal cancer.
Slattery ML; Lundgreen A; Herrick JS; Kadlubar S; Caan BJ; Potter JD; Wolff RK
Int J Cancer; 2012 Feb; 130(3):653-64. PubMed ID: 21387313
[TBL] [Abstract][Full Text] [Related]
3. Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-β-signaling pathway.
Slattery ML; Lundgreen A; Herrick JS; Caan BJ; Potter JD; Wolff RK
Carcinogenesis; 2011 Mar; 32(3):318-26. PubMed ID: 21088106
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer.
Slattery ML; Lundgreen A; Herrick JS; Wolff RK; Caan BJ
Cancer; 2011 Sep; 117(18):4175-83. PubMed ID: 21365634
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in the TGF-β signaling pathway and colon and rectal cancer risk.
Slattery ML; Herrick JS; Lundgreen A; Wolff RK
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):57-69. PubMed ID: 21068203
[TBL] [Abstract][Full Text] [Related]
6. COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.
Makar KW; Poole EM; Resler AJ; Seufert B; Curtin K; Kleinstein SE; Duggan D; Kulmacz RJ; Hsu L; Whitton J; Carlson CS; Rimorin CF; Caan BJ; Baron JA; Potter JD; Slattery ML; Ulrich CM
Cancer Causes Control; 2013 Dec; 24(12):2059-75. PubMed ID: 24022467
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor gene polymorphisms, dietary promotion of insulin resistance, and colon and rectal cancer.
Murtaugh MA; Sweeney C; Ma KN; Potter JD; Caan BJ; Wolff RK; Slattery ML
Nutr Cancer; 2006; 55(1):35-43. PubMed ID: 16965239
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer.
Slattery ML; Lundgreen A; Welbourn B; Corcoran C; Wolff RK
PLoS One; 2012; 7(5):e37312. PubMed ID: 22615972
[TBL] [Abstract][Full Text] [Related]
9. Interactions of peroxisome proliferator-activated receptor {gamma} and diet in etiology of colorectal cancer.
Murtaugh MA; Ma KN; Caan BJ; Sweeney C; Wolff R; Samowitz WS; Potter JD; Slattery ML
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1224-9. PubMed ID: 15894676
[TBL] [Abstract][Full Text] [Related]
10. Oxidative balance and colon and rectal cancer: interaction of lifestyle factors and genes.
Slattery ML; Lundgreen A; Welbourn B; Wolff RK; Corcoran C
Mutat Res; 2012 Jun; 734(1-2):30-40. PubMed ID: 22531693
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival.
Slattery ML; Curtin K; Poole EM; Duggan DJ; Samowitz WS; Peters U; Caan BJ; Potter JD; Ulrich CM
Int J Cancer; 2011 Jun; 128(11):2726-34. PubMed ID: 20949557
[TBL] [Abstract][Full Text] [Related]
12. PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States).
Slattery ML; Curtin K; Wolff R; Ma KN; Sweeney C; Murtaugh M; Potter JD; Levin TR; Samowitz W
Cancer Causes Control; 2006 Apr; 17(3):239-49. PubMed ID: 16489531
[TBL] [Abstract][Full Text] [Related]
13. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor genes and their association with colon and rectal cancer development and prognosis.
Slattery ML; Herrick JS; Bondurant KL; Wolff RK
Int J Cancer; 2012 Jun; 130(12):2974-80. PubMed ID: 21792899
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.
Slattery ML; Herrick JS; Lundgreen A; Fitzpatrick FA; Curtin K; Wolff RK
Carcinogenesis; 2010 Sep; 31(9):1604-11. PubMed ID: 20622004
[TBL] [Abstract][Full Text] [Related]
16. MAP kinase genes and colon and rectal cancer.
Slattery ML; Lundgreen A; Wolff RK
Carcinogenesis; 2012 Dec; 33(12):2398-408. PubMed ID: 23027623
[TBL] [Abstract][Full Text] [Related]
17. Energy balance, insulin-related genes and risk of colon and rectal cancer.
Slattery ML; Murtaugh M; Caan B; Ma KN; Neuhausen S; Samowitz W
Int J Cancer; 2005 May; 115(1):148-54. PubMed ID: 15688407
[TBL] [Abstract][Full Text] [Related]
18. Familial Associations of Colon and Rectal Cancers With Other Cancers.
Yu H; Hemminki A; Sundquist K; Hemminki K
Dis Colon Rectum; 2019 Feb; 62(2):189-195. PubMed ID: 30640834
[TBL] [Abstract][Full Text] [Related]
19. Variation in the CYP19A1 gene and risk of colon and rectal cancer.
Slattery ML; Lundgreen A; Herrick JS; Kadlubar S; Caan BJ; Potter JD; Wolff RK
Cancer Causes Control; 2011 Jul; 22(7):955-63. PubMed ID: 21479914
[TBL] [Abstract][Full Text] [Related]
20. Relation of family history of cancer and environmental factors to the risk of colorectal cancer: a case-control study.
Kotake K; Koyama Y; Nasu J; Fukutomi T; Yamaguchi N
Jpn J Clin Oncol; 1995 Oct; 25(5):195-202. PubMed ID: 7474407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]